KRT20 anticorps (AA 196-323)

N° du produit ABIN7871720

Cet anticorps Souris Monoclonal détecte spécifiquement KRT20 dans WB et IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour KRT20 anticorps (AA 196-323) (ABIN7871720)

Antigène: KRT20 (Keratin 20 (KRT20))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT20 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: SPM140

Détail du produit anti-KRT20 anticorps

Épitope: AA 196-323

Fonction: Cytokeratin 20 Antibody / CK20 (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogène: A recombinant human partial protein (amino acids 196-323) was used as the immunogen for this Cytokeratin 20 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the Cytokeratin 20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the Cytokeratin 20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur KRT20

Antigène: KRT20 (Keratin 20 (KRT20))

Autre désignation: Cytokeratin 20

Sujet: His MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900